Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000029

Director sold 7,497 shares at $25.90 ($194,172)

  • Director acquired 15,933 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

FOUSE JACQUALYN A · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-04-08 Exercise or conversion : show line 1 in the form 10b5-1 +15,933 156,717 D
2025-04-10 Sale : show line 2 in the form 10b5-1 −7,497 $25.90 $194,172 149,220 D
Open-market sales · 7,497 sh · avg $25.90 · $194,172

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-04-08 Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units −15,933 0 D
Loading xslF345X05/wk-form4_1744315371.xml…